WASHINGTON — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ...

The Food and Drug Monitoring Agency (BPOM) said an mRNA-based dengue vaccine developed by the University of Indonesia and ...

The Covid vaccines utilizing mRNA technology were largely responsible for the significant reductions in hospitalizations, ...

Moderna's mRNA flu vaccine could be approved by August, but federal policy and a nonfunctional advisory committee threaten ...

Under the two-year project timeline, researchers will spend the first year optimizing vaccine candidates and evaluating their ...

No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reportedSOUTH SAN ...

Probably the clearest indication of the evolutionary change at play is that the NRC estimates the changing rules will save ...

VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...

A massive, global review of mRNA vaccines has shown that they are very effective and safe. Reporting in The Lancet, ...

Spread the love“`html In an age where technology is advancing at breakneck speed, understanding the impact of modern ...

To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.

Billions of doses later, a global review has found that mRNA vaccines are safe and highly effective. Not only have they ...